By Josh Beckerman Shares of vTv Therapeutics more than doubled after the company raised $51 million in a private placement, which will be used to fund the.
By Colin Kellaher Minerva Neurosciences shares lost more than half of their value in early trading Tuesday after the U.S. Food and Drug Administration once.